| Absorption |
| Blood-Brain Barrier | BBB+ | 0.9397 |
| Human Intestinal Absorption | HIA+ | 0.9293 |
| Caco-2 Permeability | Caco2- | 0.5257 |
| P-glycoprotein Substrate | Non-substrate | 0.8790 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.9915 |
| Non-inhibitor | 0.9932 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.9553 |
| Distribution |
| Subcellular localization | Mitochondria | 0.8146 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.8326 |
| CYP450 2D6 Substrate | Non-substrate | 0.9111 |
| CYP450 3A4 Substrate | Non-substrate | 0.8218 |
| CYP450 1A2 Inhibitor | Non-inhibitor | 0.9221 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.9478 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.9470 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.9594 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.9786 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.9922 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9596 |
| Non-inhibitor | 0.9879 |
| AMES Toxicity | Non AMES toxic | 0.9447 |
| Carcinogens | Carcinogens | 0.5055 |
| Fish Toxicity | High FHMT | 0.5868 |
| Tetrahymena Pyriformis Toxicity | Low TPT | 0.8870 |
| Honey Bee Toxicity | High HBT | 0.8086 |
| Biodegradation | Ready biodegradable | 0.9640 |
| Acute Oral Toxicity | III | 0.4167 |
| Carcinogenicity (Three-class) | Non-required | 0.6821 |